GLP-1 weight-loss drug, whose full name is Glucagon-like peptide-1 receptor agonist. Initially, GLP-1 was a hormone secreted by the gastrointestinal tract mainly used for treating diabetes, but it has also been used to suppress appetite and control weight.
Viking Stock Climbs 11% Post-market on Obesity Drug Update
Viking Therapeutics Stock Climbs On Q2 EPS Beat
Expert Outlook: Eli Lilly and Co Through The Eyes Of 25 Analysts
Eli Lilly and Co Analyst Ratings
UK's NHS Prescribes Weight-Loss Drug Wegovy Less Than Expected Due To Service Shortages
Pfizer/ BioNTech Win U.K. Nod for JN.1-adjusted COVID-19 Shot